08 March 2023 : Case report
Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation
Challenging differential diagnosis, Unusual setting of medical care, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Andy Sing Ong Tang1ABCDEF, Asral Wirda Ahmad Asnawi12ADEFG*, Alex Zhi Yang Koh1ABCDEF, Siew Lian Chong1ABCE, Pek Kuen Liew1BCDEF, Veena Selvaratnam1AEF, Alina Md Fauzi12EF, Ngee Siang Lau1DEF, Sen Mui Tan1ADEFDOI: 10.12659/AJCR.938868
Am J Case Rep 2023; 24:e938868
Figure 2. Flow cytometry analysis on peripheral blood, revealed a significant population of circulating plasma cells (blue) (65% of total analyzed cells). These circulating plasma cells were found in an SSC low/CD45 dim-negative gate, with strong expression of CD38 and CD138. Interestingly, these cells expressed CD19 and surface lambda and some plasma cells exhibited dim CD20 and CD56. There were polyclonal mature B lymphocytes (purple). These cells did not exhibit any markers of immaturity. Flow cytometry analysis of the bone marrow (not shown here) revealed similar proportions of plasma cells with the same immunophenotype.*Cells in the peripheral blood were characterized by flow cytometry using tubes to evaluate plasma cells (Tube 1), B cells (Tube 2), and blasts (Tube 3). Tube 1 (plasma cells): CD20-BB515 (Becton-Dickinson)/ CD117-PE (Biolegend)/ CD38-PerCPCy5.5 (Biolegend)/ CD19-PECy7 (Biolegend)/ CD138-APC (Biolegend)/ CD45-APCFire750 (Biolegend)/ CD56-BV421 (Biolegend). Tube 2 (B cells): CD79b-FITC (Biolegend)/ slambda-PE (Dako)/ CD20-PerCPCy5.5 (Biolegend)/ CD19-PECy7 (Biolegend)/ skappa-APC (Dako)/ CD10-APCFire750 (Biolegend)/ CD5-BV421 (Biolegend)/ CD3-BV510 (Biolegend). Tube 3 (cytoplasmic blasts): nTdT-FITC (Dako)/ cIgM-PE (Dako)/ HLA-DR-PerCPCy5.5/ CD10-PECy7 (Biolegend)/ CD7-APC (Biolegend)/ CD45-APCFire750 (Biolegend)/ CD19-BV421 (Biolegend)/ CD34-BV510 (Biolegend).